Dexmedetomidine Hydrochloride for Injection Market - Global Outlook and Forecast 2022-2028

30 March 2022
Life Sciences
110 Pages
Report code : PMR-6971824

4.7

(158)

Download Free PDF sample

Dexmedetomidine Hydrochloride for Injection Market

Download FREE Report Sample

Download Free sample

Dexmedetomidine hydrochloride injection is used for sedation during tracheal intubation and mechanical ventilation in surgical patients undergoing general anesthesia. COVID-19 broke out globally, and for severe patients, this medicine is a necessity.

Dexmedetomidine Hydrochloride for Injection Market contains market size and forecasts of Dexmedetomidine Hydrochloride for Injection in global, including the following market information:

Global Dexmedetomidine Hydrochloride for Injection Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Dexmedetomidine Hydrochloride for Injection Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Dexmedetomidine Hydrochloride for Injection companies in 2021 (%)

The global Dexmedetomidine Hydrochloride for Injection market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
100mcg/ml Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Dexmedetomidine Hydrochloride for Injection include Pfizer, Accord Healthcare, Akorn, AuroMedics, Fresenius Kabi, Hikma, Mylan, Par Pharmaceuticals and Sandoz, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Dexmedetomidine Hydrochloride for Injection manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:
Global Dexmedetomidine Hydrochloride for Injection Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Dexmedetomidine Hydrochloride for Injection Market Segment Percentages, by Type, 2021 (%)

100mcg/ml
200mcg/2ml

Global Dexmedetomidine Hydrochloride for Injection Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Dexmedetomidine Hydrochloride for Injection Market Segment Percentages, by Application, 2021 (%)

Hospital
Clinics
Recovery Center

Global Dexmedetomidine Hydrochloride for Injection Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Dexmedetomidine Hydrochloride for Injection Market Segment Percentages, By Region and Country, 2021 (%)

North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Dexmedetomidine Hydrochloride for Injection revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Dexmedetomidine Hydrochloride for Injection revenues share in global market, 2021 (%)
Key companies Dexmedetomidine Hydrochloride for Injection sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Dexmedetomidine Hydrochloride for Injection sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Pfizer
Accord Healthcare
Akorn
AuroMedics
Fresenius Kabi
Hikma
Mylan
Par Pharmaceuticals
Sandoz
Sun Pharma
WG Critical Care
Athenex
Cisen Pharmaceutical
Jiangsu Hengrui Pharm
Hunan Kelun Pharmaceutical
Curegen Pharmaceutical

CHECK TODAYS BEST PRICE

Request
Chapter Price

Download
Free Sample

SECURITY ASSURED payment image

Still not found what you want?

Speak to our Custom Research Team and get the Custom Research in a budget

Custom Research

Frequently Asked Questions ?

User License

A license granted to one user.
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
Multi user License
A license granted to multiple users.
Site License
A license granted to a single business site/establishment.
Corporate License, Global License
A license granted to all employees within organisation access to the product.

Delivery Time

Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays

Payment Options

Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer

Report Delivery

Email
Hard Copy

WHY CHOOSE US

Proactive We manage our resources 24/7 to identify issues and address them before they become problems
Quality & Reliability We are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach 6 Major regions and 40+ countries level analysis accomplished
Competitive Pricing Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery